The Global Dual Chamber Implantable Cardioverter Defibrillator Market revenue was US$ revenue in 2022 and the market is forecast to reach US$ revenue by 2032, growing at a compound annual growth rate ...
SAN FRANCISCO (MarketWatch) -- Medtronic Inc. on Friday said new trial results show greater efficacy of the dual-chamber implantable cardioverter-defibrillators as compared with single-chamber ICDs in ...
The goal of the trial was to evaluate atrial pacing compared with minimal ventricular pacing (i.e., back-up pacing) among patients with reduced left ventricular (LV) function and no clinical ...
The global demand for MRI safe implantable defribrillator devices witnessed a slight fall in the first quarter of 2020 due to the spread of Covid-19 pandemic. Major attention was shifted towards ...
Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator system without an atrial lead was similar to dual-chamber ICDs ...
Patients receiving an implantable cardioverter–defibrillator (ICD) for primary prevention of sudden cardiac death with no indication for pacing are better off with a single-chamber than a dual-chamber ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results